This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Discussing the recent FDA approval of Ocrevus Zunovo, a new formulation of Ocrevus for multiple sclerosis

Ticker(s): RHHBY

Who's the expert?

Institution: Baptist Health Boca Raton Regional Hospital

  • Neurologist in Boca Raton, Florida and is affiliated with multiple hospitals in the area, including Baptist Health Boca Raton Regional Hospital and Delray Medical Center
  • Currently manages 300 patients with AD and is very familiar with the Aduhelm EMERGE/ENGAGE data.
  • Has not yet prescribed, but his colleagues have at their practice owned infusion center.

Interview Goal
to discuss the current treatment landscape and the potential of Ocrevus Zunovo, a new formulation of Ocrevus that was recently approved by the FDA for multiple sclerosis.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.